Full length article
The effect of blood staining on cervicovaginal quantitative fetal
fibronectin concentration and prediction of spontaneous preterm
birth
$
Natasha L. Hezelgrave, Katy Kuhrt*, Kate Cottam, Paul T. Seed, Rachel M. Tribe,
Andrew H. Shennan
Division of Women's Health, King's College London, Women's Health Academic Centre, King’s Health Partners, St Thomas' Hospital, London, England, UK
A R T I C L E I N F O
Article history:
Received 13 September 2016
Received in revised form 23 November 2016
Accepted 27 November 2016
Available online xxx
Keywords:
Blood staining
Fetal fibronectin
Preterm birth
A B S T R A C T
Objective: Spontaneous preterm birth is the leading cause of neonatal morbidity and mortality.
Cervicovaginal fetal fibronectin (fFN) has enhanced prediction of preterm birth and, more recently,
quantified results have become available so that management can planned more effectively and targeted
to individual women. Manufacture guidelines stipulate that fetal fibronectin (fFN) samples should be
discarded in the presence of moderate to heavy vaginal bleeding but there hasn’t yet been any formal
investigation into the effect of blood staining on fetal fibronectin concentration and subsequent preterm
birth prediction. The objective for this study was to determine the impact of blood stained swabs on
quantitative fetal fibronectin (qfFN) concentration and prediction of spontaneous preterm birth (sPTB) in
asymptomatic high-risk women.
Study design: Predefined blinded sub-analysis of a larger prospective study of qfFN in asymptomatic
women at high-risk of preterm labour. Women with and without blood stained swabs were matched for
gestational age at testing and delivery, risk factors and cervical length measurement.
Results: Median fFN concentration in blood stained swabs (n = 58) was 66 ng/ml vs. 7.5 ng/ml in the
controls (n = 58) (p < 0.0001). At 50 ng/ml threshold the false positive ratio (FPR) in blood stained was
25/33 (75.8%) vs. 8/15 (53%) in controls, (risk difference 22.4; 6.8 to 51.6, p = 0.18). At 50 ng/ml
threshold the false-negative ratio (FNR) in blood stained was 2/25 (8.0%) vs. 1/43 (2.3%) in controls (risk
difference 5.7; 17.2 to 5.9, p = 0.55).
At each threshold 10, 50 and 200 ng/ml blood stained swabs had higher sensitivity but lower specificity
for predicting preterm birth. Receiver Operating Characteristic (ROC) curve, the strongest global measure
of test performance, for prediction of delivery at <34 weeks gestation was similar in blood stained vs.
control groups. (0.78 vs. 0.84) in blood stained vs. control groups respectively.
Conclusion: Blood stained swabs have elevated qfFN concentrations but may still have predictive value,
and clinical utility. Very low fFN values (<10 ng/ml) are especially reassuring and indicate lower risk of
delivery than non-blood stained swabs. The higher false positive rate must be noted and explained to the
patient.
© 2016 Published by Elsevier Ireland Ltd.
Introduction
Spontaneous preterm birth (sPTB), birth before 37 completed
weeks’ of gestation), is the leading cause of neonatal morbidity and
mortality [1]. Prediction of sPTB in symptomatic and asymptom-
atic high-risk women has been enhanced in recent years by the use
of cervicovaginal fluid (CVF) fetal fibronectin (fFN) testing, now
widely used in clinical practice. fFN is a glycoprotein found at the
interface between chorion and decidua [2] which is usually present
in low levels in CVF from 18 weeks of gestation; high levels after
$
Natasha L. Hezelgrave is funded by a National Institute for Health Research
(NIHR) Doctoral Research Fellowship (DRF-2013-06-171). The views expressed are
those of the authors and not necessarily those of Tommy's, the NHS, the NIHR or the
Department of Health.
* Corresponding author.
E-mail address: katykuhrt24@gmail.com (K. Kuhrt).
http://dx.doi.org/10.1016/j.ejogrb.2016.11.027
0301-2115/© 2016 Published by Elsevier Ireland Ltd.
European Journal of Obstetrics & Gynecology and Reproductive Biology 208 (2017) 103–108
Contents lists available at ScienceDirect
European Journal of Obstetrics & Gynecology and
Reproductive Biology
journal homepage: www.elsevier.com/locate/ejogrb